NovaQuest
10
49M
7
0.24
1
0.20
4
- Stages of investment
- Areas of investment
Summary
NovaQuest appeared to be the VC, which was created in 1982. The main department of described VC is located in the Durham. The fund was located in North America if to be more exact in United States.
The typical case for the fund is to invest in rounds with 5-6 participants. Despite the NovaQuest, startups are often financed by Vivo Capital, Technology Partners, Essex Woodlands Healthcare Partners. The meaningful sponsors for the fund in investment in the same round are Roche Venture Fund, Radius Ventures, OrbiMed. In the next rounds fund is usually obtained by Aisling Capital, Roche Venture Fund, Radius Ventures.
Besides, a startup requires to be at the age of 6-10 years to receive the investment from the fund. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Among the most popular portfolio startups of the fund, we may highlight Arvelle Therapeutics, Artisan Pharma, Sirion Therapeutics. The fund has no exact preference in some founders of portfolio startups. We can highlight the next thriving fund investment areas, such as Biopharma, Therapeutics.
Besides them, we counted 11 critical employees of this fund in our database.
The increased amount of exits for fund were in 2014. The common things for fund are deals in the range of 10 - 50 millions dollars. The fund is generally included in less than 2 deals every year. The top activity for fund was in 2006. Despite it in 2019 the fund had an activity. Comparing to the other companies, this NovaQuest performs on 7 percentage points less the average number of lead investments. Speaking about the real fund results, this VC is 9 percentage points less often commits exit comparing to other organizations.
Investments analytics
Analytics
- Total investments
- 10
- Lead investments
- 1
- Exits
- 4
- Rounds per year
- 0.24
- Follow on index
- 0.20
- Investments by industry
- Biotechnology (8)
- Therapeutics (5)
- Health Care (5)
- Pharmaceutical (3)
- Biopharma (3) Show 3 more
- Investments by region
-
- United States (7)
- Switzerland (1)
- New Zealand (1)
- Peak activity year
- 2006
- Number of Minotaurs
- 2
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 15
- Avg. valuation at time of investment
- 212M
- Group Appearance index
- 0.90
- Avg. company exit year
- 2
- Avg. multiplicator
- 4.02
- Strategy success index
- 0.50
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
Company name | Deal date | Industry | Deal stage | Deal size | Location |
---|---|---|---|---|---|
Protemix | 04 Apr 2007 | Medical, Pharmaceutical, Diabetes | Early Stage Venture | 14M | Auckland, New Zealand |
Similar funds
By same location




By same geo focus





By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.